Search
  • 網站搜尋
亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。
返回搜索結果

CONSERVED INFLUENZA VIRUS HEMAGGLUTININ EPITOPE, ANTIBODIES TO THE EPITOPE, AND METHODS OF USE


技術優勢

Influenza virus


技術應用

The described Influenza Hemagglutinin epitope can be used in vaccines, vaccine development, as a target for drug discovery and to elicit antibodies in vivo or identify antibodies or other binding proteins in vitro (such as in libraries) that can be used as therapeutic or diagnostic products.


詳細技術說明

Dana-Farber scientists discovered a novel and conserved epitope on the stem region of group 1 influenza viruses and described human broad-spectrum neutralizing antibodies that recognize this epitope.


附加資料

Inventor: MARASCO, Wayne, A. | SUI, Jianhua | LIDDINGTON, Robert, C.
Priority Number: WO2010027818A3
IPC Current: C07K001610 | A61K0039145 | C07K001411 | G01N003350
Assignee Applicant: Dana-Farber Cancer Institute Inc. | Burnham Institute for Medical Research
Title: CONSERVED HEMAGGLUTININ EPITOPE, ANTIBODIES TO THE EPITOPE, AND METHODS OF USE | EPITOPE CONSERVÉ D'HÉMAGGLUTININE, ANTICORPS CONTRE L'ÉPITOPE ET PROCÉDÉS D'UTILISATION
Usefulness: CONSERVED HEMAGGLUTININ EPITOPE, ANTIBODIES TO THE EPITOPE, AND METHODS OF USE | EPITOPE CONSERVÉ D'HÉMAGGLUTININE, ANTICORPS CONTRE L'ÉPITOPE ET PROCÉDÉS D'UTILISATION
Summary: The immunogen and methods are useful for preventing disease or disorder caused by influenza virus; treating subject, where the subject produces an immune response that prevents or reduces the severity of an influenza infection, and where the immune response is reactive to influenza viruses within a subtype, the immune response is reactive to influenza viruses in each subtype within a cluster, the immune response is reactive to influenza viruses in each cluster within a group, the immune response is reactive to all influenza viruses in each subtype within a group, or the immune response is reactive to influenza viruses within group 1; and for screening compound for binding to F10 antibody (all claimed).
Novelty: New immunogen comprises epitope or epitope unit recognized by protective monoclonal antibody having specificity for stem region of hemagglutinin protein of influenza virus, used for preventing disease or disorder caused by influenza virus


主要類別

生物醫學


細分類別

病原


國家/地區

美國

欲了解更多信息,請點擊 這裡
Business of IP Asia Forum
桌面版